-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cosmos Health Extends And Updates Its Agreement To Acquire ZipDoctor, Inc., A Telehealth Company, From American International Holdings Corp; No Financial Terms Disclosed
Cosmos Health Extends And Updates Its Agreement To Acquire ZipDoctor, Inc., A Telehealth Company, From American International Holdings Corp; No Financial Terms Disclosed
Tapping Into the Fast Growing Multi Billion Dollar U.S. Telehealth Market
CHICAGO, IL / ACCESSWIRE / January 20, 2023 / Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has extended and updated its previously issued non-binding letter of intent to acquire ZipDoctor Inc. from American International Holdings Corp (AMIH). Cosmos Health has successfully renegotiated the acquisition price of ZipDoctor to achieve much improved payment terms. The updated letter of intent will remain effective until February 15, 2023.
ZipDoctor Inc., a wholly owned subsidiary of American International Holdings Corp. (OTC:AMIH), is a direct-to-consumer subscription-based telemedicine platform, that expects to provide its customers affordable, unlimited, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists. ZipDoctor's online telemedicine platform will be available to customers across the United States and offers English and Spanish coverage with virtual visits taking place either via the phone or through a secured video chat platform. ZipDoctor customers will be able to subscribe through their website at and are only required to pay a monthly fee, which is determined based on whether they are an individual, a couple, or a family.
Greg Siokas, Chief Executive Officer of Cosmos Health stated: "We are enthusiastic about the proposed addition of ZipDoctor to Cosmos Heath's family of companies. The telehealth industry is set for strong growth, and we believe that ZipDoctor, with the proper investment from Cosmos, can become a significant player in the space. Furthermore, we intend to expand on ZipDoctor's current primary care and mental health service offerings to include the ability to speak to a doctor to seek additional medical treatments related to and including men's and women's health and wellness issues, weight loss and other similar treatments. Furthermore, we are satisfied with the renegotiated price of the acquisition, as we are always looking to increase our returns on investment."
According to Nova One Advisor, the U.S. Telehealth market size was valued at $23.8 billion in 2021 and is expected to grow to $309.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 45.1% from 2022 to 2030. The shortage of healthcare specialists and primary care physicians in the U.S. is one of the major factors expected to accelerate the market growth in the U.S. according to the Association of American Medical Colleges (AAMC) estimation, there is an estimated shortage of both primary and specialty care physicians between 37,800 and 124,000 physicians by 2034. In 2021, the Centers for Medicare and Medicaid Services expanded reimbursable telehealth codes for the 2021 physician fee schedule.
Update on the ongoing review of COSM trading patterns: Cosmos would like to inform investors that it has recently received trading activity data from Shareholder Intelligence Services, LLC. Management is carefully reviewing the data in order to develop its next course of action.
Tapping Into the Fast Growing Multi Billion Dollar U.S. Telehealth Market
進軍快速增長的數十億美元的美國遠端醫療市場
CHICAGO, IL / ACCESSWIRE / January 20, 2023 / Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has extended and updated its previously issued non-binding letter of intent to acquire ZipDoctor Inc. from American International Holdings Corp (AMIH). Cosmos Health has successfully renegotiated the acquisition price of ZipDoctor to achieve much improved payment terms. The updated letter of intent will remain effective until February 15, 2023.
伊利諾伊州芝加哥/ACCESSWIRE/2023年1月20日/科斯莫斯健康公司(“The Company”)(納斯達克:COSM),一家擁有專有營養食品系列和藥品、品牌仿製藥、非處方藥和醫療器械分銷商的全球醫療集團今天宣佈,它已經延長並更新了之前發佈的不具約束力的收購意向書ZipDoctor Inc.來自美國國際控股公司(AMIH)。Cosmos Health已成功重新談判ZipDoctor的收購價格,以實現大幅改善的支付條件。更新後的意向書有效期至2023年2月15日。
ZipDoctor Inc., a wholly owned subsidiary of American International Holdings Corp. (OTC:AMIH), is a direct-to-consumer subscription-based telemedicine platform, that expects to provide its customers affordable, unlimited, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists. ZipDoctor's online telemedicine platform will be available to customers across the United States and offers English and Spanish coverage with virtual visits taking place either via the phone or through a secured video chat platform. ZipDoctor customers will be able to subscribe through their website at and are only required to pay a monthly fee, which is determined based on whether they are an individual, a couple, or a family.
ZipDoctor Inc.是美國國際控股公司(場外交易代碼:AMIH)的全資子公司,是一個直接面向消費者的基於訂閱的遠端醫療平臺,預計將為其客戶提供負擔得起的、不受限制的、全天候獲得董事會認證的醫生以及有執照的精神和行為健康顧問和治療師的服務。ZipDoctor的在線遠端醫療平臺將向美國各地的客戶開放,並提供英語和西班牙語的覆蓋範圍,通過電話或安全的視頻聊天平臺進行虛擬訪問。ZipDoctor的客戶將能夠通過他們的網站訂閱,只需支付月費,費用取決於他們是個人、夫婦還是家庭。
Greg Siokas, Chief Executive Officer of Cosmos Health stated: "We are enthusiastic about the proposed addition of ZipDoctor to Cosmos Heath's family of companies. The telehealth industry is set for strong growth, and we believe that ZipDoctor, with the proper investment from Cosmos, can become a significant player in the space. Furthermore, we intend to expand on ZipDoctor's current primary care and mental health service offerings to include the ability to speak to a doctor to seek additional medical treatments related to and including men's and women's health and wellness issues, weight loss and other similar treatments. Furthermore, we are satisfied with the renegotiated price of the acquisition, as we are always looking to increase our returns on investment."
Cosmos Health首席執行官格雷格·西奧卡斯表示:“我們對ZipDoctor加入Cosmos Heath公司家族的提議表示熱烈歡迎。遠端醫療行業將強勁增長,我們相信,在Cosmos的適當投資下,ZipDoctor可以成為該領域的重要參與者。此外,我們打算擴展ZipDoctor目前的初級保健和精神健康服務,以包括與醫生交談的能力,以尋求與男性和女性的健康和健康問題、減肥和其他類似治療相關的額外醫療。此外,我們對重新談判的收購價格感到滿意,因為我們一直在尋求增加我們的投資回報。“
According to Nova One Advisor, the U.S. Telehealth market size was valued at $23.8 billion in 2021 and is expected to grow to $309.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 45.1% from 2022 to 2030. The shortage of healthcare specialists and primary care physicians in the U.S. is one of the major factors expected to accelerate the market growth in the U.S. according to the Association of American Medical Colleges (AAMC) estimation, there is an estimated shortage of both primary and specialty care physicians between 37,800 and 124,000 physicians by 2034. In 2021, the Centers for Medicare and Medicaid Services expanded reimbursable telehealth codes for the 2021 physician fee schedule.
根據Nova One Advisor的數據,2021年美國遠端醫療市場規模為238億美元,預計到2030年將增長至3099億美元,2022年至2030年的復合年增長率(CAGR)為45.1%。美國醫療保健專家和初級保健醫生的短缺是預計加速美國市場增長的主要因素之一。根據美國醫學院協會(AAMC)的估計,到2034年,初級保健醫生和初級保健醫生的短缺估計在37,800到124,000名醫生之間。2021年,醫療保險和醫療補助服務中心擴大了2021年醫生費用時間表的可報銷遠端醫療代碼。
Update on the ongoing review of COSM trading patterns: Cosmos would like to inform investors that it has recently received trading activity data from Shareholder Intelligence Services, LLC. Management is carefully reviewing the data in order to develop its next course of action.
正在進行的COSM交易模式審查的最新情況:Cosmos謹通知投資者,它最近收到了來自股東情報服務公司的交易活動數據。管理層正在仔細審查這些數據,以便制定下一步行動方針。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧